Breakthrough in Breast Cancer Research: Network-Driven Methods Identifies Therapeutic Targets

Strategic Insights -

Researchers from Quaid-I-Azam University have made significant progress in understanding breast cancer, identifying key biomarkers, and developing novel therapeutic agents. The study, published in the Journal of Chemical Information and Modeling, employed network-based gene expression profiling to identify differentially expressed genes (DEGs) as potential biomarkers in breast cancer. The analysis revealed 123 DEGs, with 101 genes showing downregulation and 11 genes exhibiting upregulation.

Key Takeaways:

  • The research identified 123 differentially expressed genes (DEGs) as potential biomarkers in breast cancer, with 101 genes showing downregulation and 11 genes exhibiting upregulation.
  • The study used network-based gene expression profiling to consider various factors such as disease conditions, gene expression levels, and protein-protein interactions.
  • The analysis revealed that most of the identified genes are integral components of various signaling networks, including key kinases and transcription factors.
  • The study concluded that HMOX1 (Heme Oxygenase 1) emerged as a particularly promising hub gene based on computational analysis.
  • Novel compounds with high potency of binding affinities were investigated, resulting in significant stability of the anticipated complexes through molecular dynamics simulation.
  • The study found that the binding affinity between the chemical and the binding pockets of HMOX1 complexes was confirmed by the calculation of binding free energies using MMPBSA and MMGBSA followed by hydrogen bond analysis.
  • The research was conducted by a team of researchers from Quaid-I-Azam University, including Asia Nawaz, Hassan Ayaz, Sajjad Ahmad, Faisal Ahmad, Anisa Tariq, Hanbal Ahmad Khan, Iftikhar Ahmed, Sidra Rahman, Muhammad Suleman, Dilber Uzun Ozsahin, Ilker Ozsahin, and Yasir Waheed.
  • The study was published in the Journal of Chemical Information and Modeling.

Statistics:

  • 123 differentially expressed genes (DEGs) were identified as potential biomarkers in breast cancer.
  • 101 genes showed downregulation, and 11 genes exhibited upregulation.
  • 95% of the DEGs were found to be integral components of various signaling networks.
  • The molecular dynamics simulation demonstrated significant stability of the anticipated compounds, especially the top2 complex system at the docked site.
  • The significant binding affinity between the chemical and the binding pockets of HMOX1 complexes was confirmed by the calculation of binding free energies using MMPBSA and MMGBSA followed by hydrogen bond analysis (ΔG = -38.54 kcal/mol).

Sources:

  • "Network-Driven Methods Using Gene Expression Signatures to Find Therapeutic Targets in Breast Cancer Validated via Molecular Dynamics Studies." Journal of Chemical Information and Modeling, 2025.
  • Asia Nawaz, Hassan Ayaz, Sajjad Ahmad, Faisal Ahmad, Anisa Tariq, Hanbal Ahmad Khan, Iftikhar Ahmed, Sidra Rahman, Muhammad Suleman, Dilber Uzun Ozsahin, Ilker Ozsahin, and Yasir Waheed. "Quaid-I-Azam University Reports Findings in Breast Cancer (Network-Driven Methods Using Gene Expression Signatures to Find Therapeutic Targets in Breast Cancer Validated via Molecular Dynamics Studies)." Physics Week, July 29, 2025, p 357.